A company is progressing its regulatory filings, utilizing a facility in Stevenage, England, with the UK filing preceding the EMA application in 2027.

The entities involved

• European Medicines Agency →

  highest regulatory authority on medicines in the European Union

  • IGC Pharma, Inc. is preparing data for potential U.S. FDA review and seeking EMA support for its lead drug candidate.Mon 14:18
  • Both the FDA and the European Medicines Agency are evaluating NervGen's lead therapeutic candidate.Fri 23:04
• England →

  country in north-west Europe, part of the United Kingdom

  • Authorities are investigating an incident at a base in Fairford, with possible links to Iran and Russia.Mon 17:54
  • Burnham's administration is pushing building rate increases while the UK seeks insights from California's housing policies.Mon 17:38

Related events

• A company plans to submit regulatory applications to the FDA, EMA, and Australian TGA.Thu 13:53
• Emer Cooke has been named the executive director at the European Medicines Agency (EMA).Fri 03:35
• Oncopeptides AB's drug received a positive opinion from the EMA, leading to the European Commission making a final decision for the EU market.Sep 17
• EMA validated marketing authorization and FDA accepted NDA for Pharvaris N.V.'s lead drug.Aug 25